ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE recommends Bayer's Eylea for myopic chorodial neovascularisation
September 25, 2017Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea in the treatment of visual impairment due to myopic chorodial neovascularisation -
Avastin as effective as Eylea for treating central retinal vein occlusion
May 15, 2017NIH-funded clinical trial shows use of either drug improved vision and had few side effects. -
Regeneron's annual outlook for Eylea sales growth falls short of expectations
February 10, 2017Regeneron Pharmaceuticals said Thursday alongside its fourth-quarter financial results that it expects US sales of Eylea to grow by a single-digit percentage this year, below analyst estimates.
Pharma Sources Insight January 2025
